Inventor · disambiguated record
Michael Quigley
Also filed as: QUIGLEY MICHAEL · QUIGLEY MICHAEL G
13 granted patents·13 pending applications·71 citations·filing 1997–2025
90Inventor score
Files withBRISTOL MYERS SQUIBB CO14JANSSEN BIOTECH INC3CLARK DAVID1FIVE PRIME THERAPEUTICS INC1INTERNET SERVICES LLC1
Top patents by PatentIndex Score
26 records- 0195US9644032B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 9, 2017·12 cites·30 claims
- 0285US12379065B2Mounting systems, kits, and methods that provide access to a secondary device on an elevated support structureSCHNELL MICHAEL·Filed 2023·Granted Aug 5, 2025·1 cites·20 claims
- 0383US11466092B2Antibodies against OX-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·19 claims
- 0483US2023287064A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0581US10683357B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 16, 2020·1 cites·19 claims
- 0680US9400555B2System and method for synchronization of haptic data and media dataINTERNET SERVICES LLC·Filed 2012·Granted Jul 26, 2016·9 cites·22 claims
- 0778US2023272100A1Antibodies against ox-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0874US9226802B2Polymeric instrument for cleaning canals in endodontic proceduresMCCAFFERTY RYAN J·Filed 2012·Granted Jan 5, 2016·10 cites·19 claims
- 0974US2025236650A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1071US10544229B2Agonistic antibodies specifically binding CD40 and methods of useJANSSEN BIOTECH INC·Filed 2016·Granted Jan 28, 2020·1 cites·45 claims
- 1170US2020207816A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1269US2018312553A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1368US11603410B2Immunostimulatory agonistic antibodies for use in treating cancerBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 14, 2023·1 cites·20 claims
- 1464US6765991B1Emergency telecommunication deviceFiled 2001·Granted Jul 20, 2004·22 cites·28 claims
- 1563US2023357423A1Immunostimulatory agonistic antibodies for use in treating cancerBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1661US2015322119A1Enhancing anti-cancer activity of immunomodulatory fc fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1757US10857230B2Co-therapy comprising a small molecule CSF-1R inhibitor and an agonistic antibody that specifically binds CD40 for the treatment of cancerJANSSEN BIOTECH INC·Filed 2018·Granted Dec 8, 2020·0 cites·47 claims
- 1854US2021093719A1Co-Therapy Comprising A Small Molecule CSF-1R Inhibitor And An Agonistic Antibody That Specifically Binds CD40 For The Treatment Of CancerJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1952US12091462B2Antibodies binding to vista at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Sep 17, 2024·0 cites·20 claims
- 2050US6854846B2Fundus photographic technique to determine eye refraction for optic disc size calculationsFiled 2001·Granted Feb 15, 2005·6 cites·14 claims
- 2147US2012214125A1Endodontic burs, kits, and methods for using endodontic bursCLARK DAVID·Filed 2011·Application pending·0 cites
- 2246US2021395392A1Anti-mertk antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2345US2020405806A1Combination of a tetanus toxoid, anti-ox40 antibody and/or anti-pd-1 antibody to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2440US2021277135A1Ox-40 agonist, pd-1 pathway inhibitor and ctla-4 inhibitor combination for use in a method of treating a cancer or a solid tumorBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2539US2017188808A1Method of prescribing/making eyewear for an individualQUIGLEY MICHAEL·Filed 2016·Application pending·0 cites
- 2630US5835189AMethod and apparatus for assessing an ophthalmic patient before and after medical or surgical intervention such as laser surgeryFiled 1997·Granted Nov 10, 1998·7 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Michael Quigley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →